PharmTech Drug Digest 11.20
News|Articles|May 18, 2016

Well Care Compounding Pharmacy Issues Recall

The company recalls products due to sterility concerns.

FDA announced on May 17, 2016 that Well Care Compounding Pharmacy (Las Vegas, NV) is voluntarily recalling sterile compounded products distributed between Jan. 1–April 29, 2016. The recall comes after an FDA inspection of the facility that resulted in sterility assurance concerns.

The company states in a press release that it has not received any adverse events related to the products, as of May 17. However, because administration of a sterile product that may be compromised could result in serious infections or death, the company is advising customers to stop using the recalled products.

Source: FDA


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.